• Return to Headlines

Teligent Inc has the Highest EBITDA Growth in the Pharmaceuticals Industry (TLGT, AMPH, ANIP, SUPN, AGN)

By Shiri Gupta

Below are the three companies in the Pharmaceuticals industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Teligent Inc ranks highest with a EBITDA growth of 257.3%. Amphastar Pharma is next with a EBITDA growth of 150.2%. Ani Pharmaceutic ranks third highest with a EBITDA growth of 131.3%.

Supernus Pharmac follows with a EBITDA growth of 119.8%, and Allergan Plc rounds out the top five with a EBITDA growth of 100.9%.

SmarTrend recommended that its subscribers protect gains by selling shares of Teligent Inc on July 27th, 2017 by issuing a Downtrend alert when the shares were trading at $8.00. Since that call, shares of Teligent Inc have fallen 19.7%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: highest ebitda growth teligent inc amex:amph amphastar pharma nasdaq:anip ani pharmaceutic supernus pharmac allergan plc

Ticker(s): TLGT SUPN AGN